BridgeMD
New treatment option for Type 2 Diabetes Mellitus (T2DM)
Official title Multimodal Training Effects in Middle-Aged and Older Adults With Diabetic Sarcopenia
ClinicalTrials.gov ID: NCT07398495
What this study is testing
- What it's testing
- This study aims to investigate the effects of a 12-week multimodal exercise intervention on middle-aged and older adults (aged 45\~85 years) with Type 2 Diabetes Mellitus (T2DM). The program combines supervised training, home-based sessions, and digital support to improve muscle function, physical performance, metabolic control, and quality of life.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 85
You may be able to join if
- Diagnosed with both Type 2 Diabetes Mellitus (T2DM) and sarcopenia.
- Maintained on a stable regimen of oral hypoglycemic agents.
- Aged 45 years or older.
- Capable of communicating effectively in Mandarin or Taiwanese.
- Willing to provide informed consent or have it obtained from a legally authorized representative.
You likely can't join if
- Limited limb or joint function that prevents exercise (e.g., recent fractures or dislocations).
- Communication barriers or severe emotional/psychological issues (e.g., uncontrolled depression or severe mental illness).
- Severe cognitive impairment (e.g., dementia).
- End-stage renal disease (ESRD).
- Major comorbidities or complications, including active diabetic foot ulcers, amputation, recent myocardial infarction, severe autonomic neuropathy...
The study team makes the final eligibility decision.
Where it's taking place
- Taichung, Taiwan, Taiwan
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Taichung, Taiwan, Taiwan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.